Updates in the management of sinonasal mucosal melanoma

Meghan M Crippen1, Suat Kılıç1, Jean A Eloy1,2,3,4

  • 1Department of Otolaryngology - Head and Neck Surgery.

Abstract

Insights

Sinonasal mucosal melanoma (SNMM) treatment is evolving. Endoscopic resection with radiotherapy offers the best survival rates for this rare cancer, pending effective systemic therapies.

Area of Science:

  • Oncology
  • Head and Neck Surgery
  • Melanoma Research

Background:

  • Sinonasal mucosal melanoma (SNMM) is an aggressive malignancy with a poor prognosis.
  • Limited data exists due to the rarity of SNMM, hindering robust outcomes analysis.
  • Existing research often focuses on sinonasal malignancies broadly or cutaneous melanomas.

Purpose of the Study:

  • To provide an overview of recent literature on SNMM treatment.
  • To incorporate institutional experience with SNMM into the review.
  • To address the challenges posed by the rarity of SNMM in outcomes research.

Main Methods:

  • Review of recent literature on sinonasal mucosal melanoma treatment.
  • Analysis of institutional experience with SNMM.
  • Comparison of surgical approaches (endoscopic vs. open) and adjuvant therapies.

Main Results:

  • Endoscopic endonasal resection shows comparable oncologic outcomes to open approaches for SNMM.
  • Radiotherapy following complete resection demonstrates improved local control rates.
  • Systemic therapies for cutaneous melanoma are advancing, with early trials for SNMM targeting identified genetic mutations.

Conclusions:

  • SNMM treatment is evolving, primarily based on small retrospective studies.
  • Endoscopic resection combined with adjuvant radiotherapy may optimize disease-free survival.
  • Further research is needed to identify effective systemic therapies for SNMM.